Vycor Medical Inc
VYCO· OTC
Filed May 15, 2015 · 10-Q · 45 days after period end · 0001145443-15-000713
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Revenue | $328.55K | $358.12K | $231.67K | $432.60K |
| Net Income | -$724.18K | -$788.01K | -$662.67K | -$783.43K |
| EPS Diluted | -$0.07 | -$0.09 | -$0.11 | -$0.14 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 15, 2015 · 45 d after period end